Role of Technology for the Management of AKI in Critically Ill Patients: From Adoptive Technology to Precision Continuous Renal Replacement Therapy

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This paper reports on the continuous renal replacement therapy (CRRT) technology group recommendations and research proposals developed during the 17th Acute Dialysis Quality Initiative Meeting in Asiago, Italy. The group was tasked to address questions related to the impact of technology on acute kidney injury management. We discuss technological aspects of the decision to initiate CRRT and the components of the treatment prescription and delivery, the integration of information technology (IT) on overall patient management, the incorporation of CRRT into other ‘non-renal' extracorporeal technologies such as ECMO and ECCO<sup>2</sup>R and the use of sorbents in sepsis and propose new areas for future research. Instead of reviewing current knowledge, the group focused on developing a renovated research agenda that reflects current and future technological advances, centered on innovations in new equipment, membranes and IT that will permit the integration of patient care and decision-making processes for years to come.

Related collections

Author and article information

Journal

Journal ID (publisher-id): BPU

Journal ID (nlm-ta): Blood Purif

Journal ID (doi): 10.1159/issn.0253-5068

Title: Blood Purification

Publisher: S. Karger AG

ISSN (Print): 0253-5068

ISSN (Electronic): 1421-9735

Publication date Subscription-year: 2016

Publication date (Print): September 2016

Publication date (Electronic): 26 August 2016

Volume: 42

Issue: 3

Pages: 248-265

Affiliations

^aDepartment of Medicine, Albany Medical College, Albany N.Y., and ^bDepartment of Critical Care Medicine, Center for Critical Care Nephrology, University of Pittsburgh School of Medicine, Pittsburgh, Pa., USA; ^cDepartment of Intensive Care, Austin Hospital, Melbourne, Australia; ^dDepartment of Intensive Care, Universitair Ziekenhuis Brussel, VUB University, Brussels, Belgium; ^eDepartment of Health Science, Section of Anaesthesiology and Intensive Care, University of Florence, Florence, and ^fDepartment of Nephrology and International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy

Author notes

*Professor Claudio Ronco, Department of Nephrology and International Renal Research, Institute of Vicenza, San Bortolo Hospital, IT-36100 Vicenza (Italy), E-Mail cronco@goldnet.it

Article

Publisher ID: 448527 Other ID: Blood Purif 2016;42:248-265

DOI: 10.1159/000448527

PubMed ID: 27562206

SO-VID: b48dba74-9440-4b56-80b7-0b5c9aecf7a7

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

History

Page count

Figures: 8, Tables: 2, References: 53, Pages: 18

Comments

Comment on this article

scite_

Cited by 17

See all cited by

- Version 1

Call for Papers: Green Renal Replacement Therapy: Caring for the Environment

Submit here before September 30, 2024